148 related articles for article (PubMed ID: 11081390)
1. Prevention of autoimmune hearing loss in MRL/lpr mice by bone marrow transplantation.
Lee S; Iwai H; Sugiura K; Takeuchi K; Kushida T; Tomoda K; Inaba M; Yamashita T; Ikehara S
Bone Marrow Transplant; 2000 Oct; 26(8):887-92. PubMed ID: 11081390
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow transplantation as a strategy for the treatment of autoimmune hearing loss in MRL/Mp-lpr/lpr mice.
Iwai H; Lee S; Inaba M; Baba S; Yamashita T; Ikehara S
J Neuroimmunol; 2005 Nov; 168(1-2):76-82. PubMed ID: 16146652
[TBL] [Abstract][Full Text] [Related]
3. Requirement of donor-derived stromal cells in the bone marrow for successful allogeneic bone marrow transplantation. Complete prevention of recurrence of autoimmune diseases in MRL/MP-Ipr/Ipr mice by transplantation of bone marrow plus bones (stromal cells) from the same donor.
Ishida T; Inaba M; Hisha H; Sugiura K; Adachi Y; Nagata N; Ogawa R; Good RA; Ikehara S
J Immunol; 1994 Mar; 152(6):3119-27. PubMed ID: 8144907
[TBL] [Abstract][Full Text] [Related]
4. Prevention of lpr-graft-versus-host disease and transfer of autoimmune diseases in normal C57BL/6 mice by transplantation of bone marrow cells plus bones (stromal cells) from MRL/lpr mice.
Miyashima S; Nagata N; Nakagawa T; Hosaka N; Takeuchi K; Ogawa R; Ikehara S
J Immunol; 1996 Jan; 156(1):79-84. PubMed ID: 8598497
[TBL] [Abstract][Full Text] [Related]
5. Presence of donor-derived thymic epithelial cells in [B6-->MRL/lpr] mice after allogeneic intra-bone marrow-bone marrow transplantation (IBM-BMT).
Takaki T; Hosaka N; Miyake T; Cui W; Nishida T; Inaba M; Ikehara S
J Autoimmun; 2008 Dec; 31(4):408-15. PubMed ID: 19022623
[TBL] [Abstract][Full Text] [Related]
6. Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation.
Hosaka N; Ryu T; Miyake T; Cui W; Nishida T; Takaki T; Inaba M; Ikehara S
Clin Exp Immunol; 2007 Mar; 147(3):555-63. PubMed ID: 17302907
[TBL] [Abstract][Full Text] [Related]
7. Decreased cochlear DNA receptor staining in MRL.MpJ-Fas(lpr) autoimmune mice with hearing loss.
Kaylie DM; Hefeneider SH; Kempton JB; Siess DC; Vedder CT; Merkens LS; Trune DR
Laryngoscope; 2001 Jul; 111(7):1275-80. PubMed ID: 11568554
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplantation: a new strategy for intractable diseases.
Ikehara S
Drugs Today (Barc); 2002 Feb; 38(2):103-11. PubMed ID: 12532188
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow transfers in X-irradiated mice congenic at the lpr locus: some paradoxical effects.
Mosbach-Ozmen L; Loor F
Thymus; 1987; 9(4):197-210. PubMed ID: 3313828
[TBL] [Abstract][Full Text] [Related]
10. Optimal protocol for total body irradiation for allogeneic bone marrow transplantation in mice.
Cui YZ; Hisha H; Yang GX; Fan TX; Jin T; Li Q; Lian Z; Ikehara S
Bone Marrow Transplant; 2002 Dec; 30(12):843-9. PubMed ID: 12476275
[TBL] [Abstract][Full Text] [Related]
11. Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation.
Kushida T; Inaba M; Takeuchi K; Sugiura K; Ogawa R; Ikehara S
Blood; 2000 Mar; 95(5):1862-8. PubMed ID: 10688849
[TBL] [Abstract][Full Text] [Related]
12. New strategies for BMT, organ transplantation, and regeneration therapy.
Ikehara S
Hematology; 2003 Apr; 8(2):77-81. PubMed ID: 12745656
[TBL] [Abstract][Full Text] [Related]
13. A new bone marrow transplantation method for stem cell disorders.
Ikehara S
Ann N Y Acad Sci; 2009 Sep; 1173():774-80. PubMed ID: 19758228
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT).
Karussis DM; Vourka-Karussis U; Lehmann D; Abramsky O; Ben-Nun A; Slavin S
Clin Exp Immunol; 1995 Apr; 100(1):111-7. PubMed ID: 7697909
[TBL] [Abstract][Full Text] [Related]
15. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
Faust J; Menke J; Kriegsmann J; Kelley VR; Mayet WJ; Galle PR; Schwarting A
Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow cells as an origin of immune-mediated hearing loss.
Iwai H; Lee S; Baba S; Tomoda K; Inaba M; Ikehara S; Yamashita T
Acta Otolaryngol; 2004 Jan; 124(1):8-12. PubMed ID: 14977070
[TBL] [Abstract][Full Text] [Related]
17. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice.
Kushida T; Inaba M; Hisha H; Ichioka N; Esumi T; Ogawa R; Iida H; Ikehara S
Blood; 2001 May; 97(10):3292-9. PubMed ID: 11342461
[TBL] [Abstract][Full Text] [Related]
18. Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice.
Matsumoto K; Watanabe N; Akikusa B; Kurasawa K; Matsumura R; Saito Y; Iwamoto I; Saito T
Arthritis Rheum; 2003 Feb; 48(2):486-94. PubMed ID: 12571859
[TBL] [Abstract][Full Text] [Related]
19. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
[TBL] [Abstract][Full Text] [Related]
20. Aldosterone (mineralocorticoid) equivalent to prednisolone (glucocorticoid) in reversing hearing loss in MRL/MpJ-Fas1pr autoimmune mice.
Trune DR; Kempton JB; Kessi M
Laryngoscope; 2000 Nov; 110(11):1902-6. PubMed ID: 11081607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
